WHO ICTRP trial
A randomized, Double-Blind, Placebo-controlled Study of the Efficacy and Safety…
JPRN-jRCT2080220566 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220566 |
|---|---|
| Public title | A randomized, Double-Blind, Placebo-controlled Study of the Efficacy and Safety of TAK-242 Versus Placebo in Subjects With Sepsis Induced Cardiovascular and Respiratory Failure |
| Scientific title | A randomized, Double-Blind, Placebo-controlled Study of the Efficacy and Safety of TAK-242 Versus Placebo in Subjects With Sepsis Induced Cardiovascular and Respiratory Failure |
| Primary sponsor | Takeda Pharmaceutical Company Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Subjects with Sepsis Induced Cardiovascular and Respiratory Failure |
| Interventions | investigational material(s) Generic name etc : TAK-242 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Injection |
| Registration date | Oct 6, 2008 |
| Target size | 2500 |
| Secondary IDs | JapicCTI-080588 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: